Advanced Filters
noise

Minatoga, Japan Clinical Trials

A listing of Minatoga, Japan clinical trials actively recruiting patients volunteers.

Found 64,772 clinical trials
L Liesbet Lauwereins, Msc.

Personalized Care Pathways for Bowel Symptoms in Rectal Cancer Patients_contributing Factors (Treatable)

Colorectal cancer is the 2nd and 3rd most common cancer in respectively women and men, of which about 40% is located in the rectum. The gold standard treatment for rectal cancer (RC) is a low anterior resection, combined with chemoradiotherapy. However, this treatment will negatively impact different aspects of bowel …

18 years of age All Phase N/A
Q Qiufan Zheng, MD

The Optimal Radioimmunotherapy Combinations for Advanced TNBC

This study aims to explore the best combination patterns of radiotherapy and immunotherapy for advanced triple-negative breast cancer (TNBC).

years of age All Phase 2
S Shuiyuan Xiao, Ph.D.

Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure

Mental health art exhibitions, as an intervention strategy integrating artistic expression and social contact, have the potential to positively impact the elimination of stigma and discrimination associated with mental health problems. Based on a two-phase experimental design, this study aims to evaluate the effect of a real-world mental health art …

18 years of age All Phase N/A
P Paolo Sassu, Medical Doctor, Surgeon, PhD

Clinical Evaluation of Intuitive, Bidirectional Strategies for the Control of Multi-articulated Prostheses for Upper Limb Amputation

The investigators propose to validate a non-invasive upper limb prosthesis capable of combining: 1) intuitive movement control through machine learning applied to myoelectric signals, and 2) vibrotactile sensory feedback in response to touch and object release events. The prosthesis is composed at the minimum of skin-surface electrodes for myoelectric signals, …

18 - 65 years of age All Phase N/A

To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of refractory or relapsed PTCL.

18 - 80 years of age All Phase 1
B Benedikt L. Amann, MD

Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia

Fibromyalgia (FM) is a generalized, widespread chronic pain disorder and has an estimated prevalence of 2%-4% in the general population. Current pharmacological and psychological interventions frequently produce limited benefits in FM patients. Due to FM's strong association with psychological trauma causing neurobiological alterations in stress response, a trauma-focused psychotherapy is …

18 - 70 years of age Female Phase N/A
M Mary Paine, PhD, RPh

Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel

The goal of this clinical trial is to determine how two different doses of cannabidiol (CBD), given as a hemp product, change the blood concentrations of the drug clopidogrel in the body. Results will be used to help design future studies and to assist healthcare providers in informing their patients …

21 - 64 years of age All Phase N/A
J Justin M Riddle, PhD

Causal Role of the Aperiodic Signal for Working Memory

Working memory (WM) is the ability to hold relevant information in mind in the absence of sensory input. The capacity for WM is a foundation for cognitive control and higher cognitive function more broadly. Previous research demonstrated that during the delay period of WM tasks, oscillatory electrical activity in the …

18 - 35 years of age All Phase N/A

A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

The purpose of this trial is to evaluate safety and efficacy of intrathecal delivery of VGN-R13 as a treatment of Amyotrophic Lateral Sclerosis (ALS).

18 years of age All Phase N/A
P Philip Ryan, Dr

A Study of YP05002 in Healthy Participants

This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants

18 - 65 years of age All Phase 1

Simplify language using AI